DE69635806D1 - Diphosphonat derivate von therapeutisch wirksamen stoffen - Google Patents

Diphosphonat derivate von therapeutisch wirksamen stoffen

Info

Publication number
DE69635806D1
DE69635806D1 DE69635806T DE69635806T DE69635806D1 DE 69635806 D1 DE69635806 D1 DE 69635806D1 DE 69635806 T DE69635806 T DE 69635806T DE 69635806 T DE69635806 T DE 69635806T DE 69635806 D1 DE69635806 D1 DE 69635806D1
Authority
DE
Germany
Prior art keywords
active substances
therapeutically active
diphosphonate derivatives
urinary tract
diphosphonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69635806T
Other languages
English (en)
Inventor
Dan Farcasiu
F Hartmann
Pal Herczegh
J Sztaricskai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ELIZANOR BIOPHARMACEUTICALS IN
Original Assignee
ELIZANOR BIOPHARMACEUTICALS IN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ELIZANOR BIOPHARMACEUTICALS IN filed Critical ELIZANOR BIOPHARMACEUTICALS IN
Application granted granted Critical
Publication of DE69635806D1 publication Critical patent/DE69635806D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025Esters of poly(thio)phosphonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/60Quinoline or hydrogenated quinoline ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69635806T 1995-06-07 1996-06-06 Diphosphonat derivate von therapeutisch wirksamen stoffen Expired - Lifetime DE69635806D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/478,245 US5880111A (en) 1995-06-07 1995-06-07 Therapeutic derivations of diphosphonates
PCT/US1996/009259 WO1996040190A1 (en) 1995-06-07 1996-06-06 Diphosphonate derivatives of therapeutic agents

Publications (1)

Publication Number Publication Date
DE69635806D1 true DE69635806D1 (de) 2006-04-20

Family

ID=23899129

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635806T Expired - Lifetime DE69635806D1 (de) 1995-06-07 1996-06-06 Diphosphonat derivate von therapeutisch wirksamen stoffen

Country Status (7)

Country Link
US (1) US5880111A (de)
EP (1) EP0831869B1 (de)
AT (1) ATE317263T1 (de)
AU (1) AU715705B2 (de)
CA (1) CA2224069A1 (de)
DE (1) DE69635806D1 (de)
WO (1) WO1996040190A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0944635A4 (de) * 1996-10-09 2000-07-05 Elizanor Biopharmaceuticals In Therapeutische diphosphonatverbindungen
US5998390A (en) * 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
EP1881974A4 (de) * 2005-04-21 2011-03-16 Targanta Therapeutics Inc Phosphonierte fluorchinoline, antibakterielle analoga davon und verfahren zur vorbeugung und behandlung von knochen- und gelenkinfektionen
JP5368092B2 (ja) * 2005-08-11 2013-12-18 ターガンタ セラピュティクス,インコーポレイティド ホスホン化リファマイシン類および骨と関節感染の予防と治療のためのその投与法
WO2007138381A2 (en) * 2005-10-14 2007-12-06 Targanta Therapeutics Inc. Phosphonated oxazolidinones and uses thereof for the prevention and treatment of bone and joint infections
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
WO2008077241A1 (en) 2006-12-22 2008-07-03 Targanta Therapeutics, Inc. Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections
DE102008054524B4 (de) * 2008-12-11 2021-06-17 Koenig & Bauer Ag Verfahren zum Ablegen von Bogen auf einem Auslegerstapel im Ausleger einer bogenverarbeitenden Maschine und Vorrichtung hierfür
US10865220B2 (en) * 2016-06-03 2020-12-15 Biovinc, Llc Bisphosphonate quinolone conjugates and uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186268A (en) * 1979-01-29 1980-01-29 E. R. Squibb & Sons, Inc. Mercaptoacylpyrrolidine phosphonic acids and related compounds
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
ES8802468A1 (es) * 1985-05-02 1988-07-16 Research Corp Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
US5057506A (en) * 1985-05-24 1991-10-15 Ciba-Geigy Corporation Certain phosphonic acids and derivatives useful for the treatment of disorders responsive to N-methyl-D-aspartate receptor blockade
ATE64397T1 (de) * 1986-11-21 1991-06-15 Ciba Geigy Ag Aromatisch substituierte azacycloalkylalkandiphosphons|uren.
IL84497A (en) * 1986-11-21 1994-10-21 Ciba Geigy Ag History 2-) Imidazol-1-yl (ethane-1,1-diphosphonic acid, their preparation and pharmaceutical preparations containing them
IL84494A (en) * 1986-11-21 1992-08-18 Ciba Geigy Ag Heteroaryl substituted aminomethane-diphosphonic acids,their preparation and pharmaceutical compositions containing them
IL84731A0 (en) * 1986-12-19 1988-05-31 Norwich Eaton Pharma Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them
FR2611203B1 (fr) * 1987-02-20 1989-06-09 Sturtz Georges Analogues gem-diphosphoniques d'amethopterine (methotrexate) et de derives deaza-n-10 amethopterine. leur preparation et les compositions pharmaceutiques qui les contiennent
GB8808138D0 (en) * 1988-04-07 1988-05-11 Leo Pharm Prod Ltd Chemical compounds
US4990503A (en) * 1988-08-12 1991-02-05 Yamanouchi Pharmaceutical Co., Ltd. Heterocyclic bisphosphonic acid derivatives
AU642336B2 (en) * 1991-02-07 1993-10-14 Kaken Pharmaceutical Co., Ltd. Bisphosphonic acid derivatives, their intermediates and bone resorption inhibitors containing them as active ingredients
EP0521622B1 (de) * 1991-07-03 1997-08-13 PHARMACIA & UPJOHN COMPANY Pyrazolopyrimiden- und Pyrimidinylbisphosphonsäureester als entzündungshemmende Mittel
US5128328A (en) * 1991-10-25 1992-07-07 American Home Products Corporation Heterocyclic bisphosphonic acid derivatives
FR2683528A1 (fr) * 1991-11-12 1993-05-14 Bretagne Occidentale Universit Prodrogues et analogues gem-bisphosphoniques d'antiinflammatoires non-sterouidiens de type arylacetique ou arylpropionique.
EP0663919A1 (de) * 1992-10-09 1995-07-26 PHARMACIA & UPJOHN COMPANY Pyrimidin bisphosphonsäureestern als anti-inflammatorisches mittel
US5543396A (en) * 1994-04-28 1996-08-06 Georgia Tech Research Corp. Proline phosphonate derivatives

Also Published As

Publication number Publication date
ATE317263T1 (de) 2006-02-15
US5880111A (en) 1999-03-09
EP0831869B1 (de) 2006-02-08
CA2224069A1 (en) 1996-12-19
AU6156796A (en) 1996-12-30
AU715705B2 (en) 2000-02-10
EP0831869A4 (de) 1999-04-21
WO1996040190A1 (en) 1996-12-19
EP0831869A1 (de) 1998-04-01

Similar Documents

Publication Publication Date Title
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
CY1109437T1 (el) ΣΥΝΘΕΣΕΙΣ β-ΓΛΥΚΑΝΩΝ ΚΑΙ ΕΙΔΙΚΩΝ ΑΝΟΣΟΣΦΑΙΡΙΝΩΝ
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
TR200000059T2 (tr) Piridin türevleri
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
DE69907977D1 (de) Pyrrolobenzodiazepine
GEP20063799B (en) Tropane derivatives useful in therapy
ATE233274T1 (de) Oxyiminopregnancarbolactone
MY119375A (en) Treatment of tinnitus using neuroprotective agents
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
NO994330D0 (no) Metode for behandling av en tumor
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
DE69635806D1 (de) Diphosphonat derivate von therapeutisch wirksamen stoffen
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
DE60013486D1 (de) Verbindungen
SE0003476D0 (sv) Compounds
DE60128100D1 (de) Analgetisches arzneimittel
DE60320034D1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
SE0004101D0 (sv) New use
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
ATE250610T1 (de) Kaliumkanal-blockierende mittel
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
SE0100684D0 (sv) New subject-matter
RS49520B (sr) Antimikrobno aktivne smeše

Legal Events

Date Code Title Description
8332 No legal effect for de